I think the signs are all positive it's just people are impatient.
the cogs started turning from initial Euopean sales last year and since then more and more centres have got on board which is positive BUT the cycle must take place before the numbers start to increase.
IMO the new centres on board starting with Europe have to test the product for themselves over a certain amount of procedures to gauge the ease of use and how effective it is. (This could take months). Next step once they have decided to go with Cardiocel is to use up the previous products they have, these centres can't just sell on existing stock they have or throw it away either.
To surmise I think (if Cardiocel is superior like we hope) these centres will be switching over one by one and it'll be at this point the number of patches sold and revenue will increase exponentially.
There will be a corner turned, a surprise quarterly, whether than shows up in Jan or April I'm not sure but if Cardiocel is superior it will show up.
- Forums
- ASX - By Stock
- Ann: AGM - Presentation to Shareholders
I think the signs are all positive it's just people are...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.50 |
Change
0.210(0.99%) |
Mkt cap ! $413.0M |
Open | High | Low | Value | Volume |
$21.50 | $21.50 | $21.00 | $247.6K | 11.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $21.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.50 | 244 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 21.200 |
1 | 412 | 21.150 |
1 | 493 | 21.100 |
1 | 949 | 21.000 |
1 | 500 | 20.800 |
Price($) | Vol. | No. |
---|---|---|
21.500 | 244 | 1 |
21.600 | 300 | 1 |
21.700 | 421 | 1 |
22.200 | 107 | 1 |
22.610 | 254 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$21.21 |
  |
Change
0.210 ( 0.09 %) |
|||
Open | High | Low | Volume | ||
$21.19 | $21.21 | $21.19 | 143 | ||
Last updated 14.24pm 06/05/2024 ? |
Featured News
AVR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online